Immunogenesis

We track 1 ClinicalTrials.gov studies led by Immunogenesis. The portfolio skews toward Phase 1 (1 trials).

1 clinical trials sponsored by Immunogenesis.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 1
100%

Trial Status Breakdown

Trials by Immunogenesis

A Phase 1a/1b, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of IMGS-001 in Patients With Relapsed or Refractory Advanced Solid Tumors

NCT06014502 · RECRUITING · Phase 1

Frequently Asked Questions

How many clinical trials does Immunogenesis sponsor?

Immunogenesis currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.

What conditions does Immunogenesis research?

Immunogenesis conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Immunogenesis recruiting for clinical trials?

Yes, Immunogenesis currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More